{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:56:46Z","timestamp":1765544206439},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.smrv.2004.06.003","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T13:09:08Z","timestamp":1092748148000},"page":"333-338","source":"Crossref","is-referenced-by-count":12,"title":["An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy"],"prefix":"10.1016","volume":"8","author":[{"given":"Emmanuel","family":"Mignot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2004.06.003_BIB1","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2004.03.002","article-title":"Pharmacotherapy for excessive daytime sleepiness","author":"Banerjee","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2004.06.003_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100119304","article-title":"The treatment of narcolepsy\u2013cataplexy with nocturnal gamma-hydroxybutyrate","volume":"6","author":"Broughton","year":"1979","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.smrv.2004.06.003_BIB3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-0082(96)00070-6","article-title":"Pharmacological aspects of human and canine narcolepsy","volume":"52","author":"Nishino","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.smrv.2004.06.003_BIB4","first-page":"704","article-title":"Pharmacotherapy in narcolepsy","volume":"21","author":"Akimoto","year":"1960","journal-title":"Dis Nerv Syst"},{"key":"10.1016\/j.smrv.2004.06.003_BIB5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM197110282851802","article-title":"Treatment of intractable narcolepsy with a monoamine oxidase inhibitor","volume":"285","author":"Wyatt","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.smrv.2004.06.003_BIB6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/sleep\/9.1.275","article-title":"Viloxazine hydrochloride in narcolepsy: a preliminary report","volume":"9","author":"Guilleminault","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2004.06.003_BIB7","first-page":"113","article-title":"Status cataplecticus induced by abrupt withdrawal of clomipramine","volume":"17","author":"Martinez-Rodriguez","year":"2002","journal-title":"Neurologia"},{"key":"10.1016\/j.smrv.2004.06.003_BIB8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/sleep\/16.8.706","article-title":"Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds","volume":"16","author":"Nishino","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2004.06.003_BIB9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.smrv.2004.06.003_BIB10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02244985","article-title":"Binding of antidepressants to human brain receptors: focus on newer generation compounds","volume":"114","author":"Cusack","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.smrv.2004.06.003_BIB11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","author":"Mignot","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.smrv.2004.06.003_BIB12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.smrv.2004.06.003_BIB13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0022-510X(66)90001-3","article-title":"Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran)","volume":"3","author":"Hishikawa","year":"1966","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.smrv.2004.06.003_BIB14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.134.2.183","article-title":"Protriptyline: an effective agent in the treatment of the narcolepsy\u2013cataplexy syndrome and hypersomnia","volume":"134","author":"Schmidt","year":"1977","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.smrv.2004.06.003_BIB15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0028-3908(03)00268-5","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.smrv.2004.06.003_BIB16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4088\/JCP.v61n0406","article-title":"Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine","volume":"61","author":"Kennedy","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.smrv.2004.06.003_BIB17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/sleep\/24.3.282","article-title":"Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study","volume":"24","author":"Larrosa","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2004.06.003_BIB18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00003495-200464020-00005","article-title":"Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder","volume":"64","author":"Simpson","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2004.06.003_BIB19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.smrv.2004.06.003_BIB20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neubiorev.2003.11.003","article-title":"Amphetamine neurotoxicity: accomplishments and remaining challenges","volume":"27","author":"McCann","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.smrv.2004.06.003_BIB21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/00912709922007534","article-title":"A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers","volume":"39","author":"Wong","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.smrv.2004.06.003_BIB22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2004.06.003_BIB23","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1016\/j.smrv.2004.06.003_BIB24","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2004.06.003_BIB25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-200342020-00002","article-title":"Clinical pharmacokinetic profile of modafinil","volume":"42","author":"Robertson","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.smrv.2004.06.003_BIB26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study","volume":"64","author":"DeBattista","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.smrv.2004.06.003_BIB27","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.2165\/00003495-200363240-00003","article-title":"Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management","volume":"63","author":"Happe","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.smrv.2004.06.003_BIB28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.2211007","article-title":"Should a pharmaceutical be approved for the broad indication of excessive sleepiness?","volume":"167","author":"Pack","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.smrv.2004.06.003_BIB29","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2004.01.004","article-title":"Pharmacotherapy for cataplexy","author":"Houghton","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2004.06.003_BIB30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.smrv.2004.06.003_BIB31","first-page":"273","article-title":"The effects of gamma-hydroxybutyrate on sleep","volume":"12","author":"Mamelak","year":"1977","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.smrv.2004.06.003_BIB32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI119587","article-title":"Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men","volume":"100","author":"Van Cauter","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.smrv.2004.06.003_BIB33","first-page":"646","article-title":"On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy","volume":"26","author":"Mignot","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2004.06.003_BIB34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2004.06.003_BIB35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079204000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079204000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T22:23:07Z","timestamp":1549318987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079204000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S1087079204000590"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2004.06.003","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}